Buy It or Sell It? Ocugen Inc (NASDAQ:OCGN) Attempts To Recover

Ocugen Inc (NASDAQ:OCGN) stock is trading with modest gains in the pre-market session after the news. The stock has been under pressure over the past week with a fall of 36%.

Market Reaction

As of 7:45, OCGN stock is up by 3.19% at $6.46 with more than 446 shares traded hands.

Major Trigger:

Ocugen Inc. Set to Join Russell 3000® Index

Key Highlights:

  • announced that it is set to join the broad-market Russell 3000® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, 2021, according to a preliminary list of additions posted June 4, 2021.
  • The annual Russell indexes reconstitution captures the 4,000 largest US stocks as of May 7, 2021, ranking them by total market capitalization. Membership in the US all-cap Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes.
  • FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings, and style attributes. Salarius Pharmaceuticals Inc (NASDAQ:SLRX) is trading up in the pre-market session on Wednesday. The stock has been witnessing solid rally over the past 6-month with a jump 45%.

Key Quote:

“As part of the reconstitution process to ensure that new and growing equities are included, we are pleased to be added to the Russell 3000® index which measures the performance of the largest US companies representing approximately 98% of the investable US equity market,” said Sanjay Subramanian, CFO and Head of Corporate Development of Ocugen.

Market Reaction

As of 8:47, SLRX is up by 0.83% to $1.22 with 122K shares traded hands.

Related Posts

About The Author